Credit Suisse’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,290
| Closed | -$566K | – | 3221 |
|
|
2023
Q1 | $566K | Hold |
7,290
| – | – | ﹤0.01% | 2668 |
|
|
2022
Q4 | $567K | Buy |
+7,290
| New | +$567K | ﹤0.01% | 2691 |
|
|
2022
Q2 | – | Sell |
-6,323
| Closed | -$504K | – | 4202 |
|
|
2022
Q1 | $504K | Buy |
+6,323
| New | +$504K | ﹤0.01% | 2952 |
|
|
2020
Q1 | – | Sell |
-1,133,000
| Closed | -$72.7M | – | 3467 |
|
|
2019
Q4 | $72.7M | Buy |
+1,133,000
| New | +$72.7M | 0.05% | 303 |
|
|
2016
Q3 | – | Sell |
-51,722
| Closed | -$3.03M | – | 3814 |
|
|
2016
Q2 | $3.03M | Buy |
51,722
+20,284
| +65% | +$1.19M | ﹤0.01% | 1796 |
|
|
2016
Q1 | $1.81M | Buy |
31,438
+27,092
| +623% | +$1.56M | ﹤0.01% | 2033 |
|
|
2015
Q4 | $284K | Sell |
4,346
-72,460
| -94% | -$4.74M | ﹤0.01% | 3481 |
|
|
2015
Q3 | $4.84M | Buy |
76,806
+69,576
| +962% | +$4.38M | 0.01% | 1489 |
|
|
2015
Q2 | $512K | Sell |
7,230
-9,688
| -57% | -$686K | ﹤0.01% | 3439 |
|
|
2015
Q1 | $1.19M | Sell |
16,918
-30,073
| -64% | -$2.11M | ﹤0.01% | 2586 |
|
|
2014
Q4 | $3.02M | Buy |
46,991
+34,897
| +289% | +$2.24M | ﹤0.01% | 1903 |
|
|
2014
Q3 | $769K | Sell |
12,094
-6,243
| -34% | -$397K | ﹤0.01% | 2919 |
|
|
2014
Q2 | $1.14M | Sell |
18,337
-18,912
| -51% | -$1.17M | ﹤0.01% | 2776 |
|
|
2014
Q1 | $2.17M | Sell |
37,249
-622
| -2% | -$36.3K | ﹤0.01% | 2152 |
|
|
2013
Q4 | $2.01M | Sell |
37,871
-119,114
| -76% | -$6.33M | ﹤0.01% | 2281 |
|
|
2013
Q3 | $7.51M | Buy |
156,985
+76,911
| +96% | +$3.68M | 0.01% | 1109 |
|
|
2013
Q2 | $3.64M | Buy |
+80,074
| New | +$3.64M | ﹤0.01% | 1566 |
|